Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-17

Clinical Trial Update: Oral Omega-3 for Reduction of Kidney Scar Due to Pyelonephritis in Children [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating whether oral omega-3 can reduce kidney scarring in children after acute pyelonephritis. The study status is currently unk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Shahid Beheshti University | Conditions: Acute Pyelonephritis(APN) | Phase 3 | Status: UNKNOWN